Kyle Mikson
Stock Analyst at Canaccord Genuity
(2.24)
# 3,037
Out of 5,182 analysts
117
Total ratings
39.77%
Success rate
-1.06%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAI Caris Life Sciences | Maintains: Hold | $30 → $22 | $19.13 | +15.00% | 3 | Mar 13, 2026 | |
| XGN Exagen | Maintains: Buy | $15 → $10 | $2.97 | +236.70% | 6 | Mar 11, 2026 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $0.79 | +26.79% | 7 | Mar 5, 2026 | |
| GH Guardant Health | Maintains: Buy | $125 → $135 | $82.21 | +64.21% | 11 | Feb 20, 2026 | |
| GRAL GRAIL | Maintains: Buy | $105 → $80 | $48.04 | +66.53% | 6 | Feb 20, 2026 | |
| BDSX Biodesix | Maintains: Buy | $20 | $13.36 | +49.70% | 6 | Feb 17, 2026 | |
| ILMN Illumina | Maintains: Hold | $130 → $150 | $126.96 | +18.15% | 15 | Jan 26, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $60.98 | +178.78% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $23.58 | -15.18% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $45.98 | +73.99% | 3 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $8 | $3.39 | +135.99% | 8 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $285 | $201.90 | +41.16% | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $50 | $23.53 | +112.49% | 6 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $32.44 | +32.55% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $122.59 | +34.59% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.45 | +106.90% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.28 | +134.38% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.16 | +1,143.78% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $9.28 | +15,805.17% | 1 | Mar 30, 2021 |
Caris Life Sciences
Mar 13, 2026
Maintains: Hold
Price Target: $30 → $22
Current: $19.13
Upside: +15.00%
Exagen
Mar 11, 2026
Maintains: Buy
Price Target: $15 → $10
Current: $2.97
Upside: +236.70%
Quantum-Si incorporated
Mar 5, 2026
Maintains: Hold
Price Target: $1.5 → $1
Current: $0.79
Upside: +26.79%
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $125 → $135
Current: $82.21
Upside: +64.21%
GRAIL
Feb 20, 2026
Maintains: Buy
Price Target: $105 → $80
Current: $48.04
Upside: +66.53%
Biodesix
Feb 17, 2026
Maintains: Buy
Price Target: $20
Current: $13.36
Upside: +49.70%
Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130 → $150
Current: $126.96
Upside: +18.15%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $60.98
Upside: +178.78%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $23.58
Upside: -15.18%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $45.98
Upside: +73.99%
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $3.39
Upside: +135.99%
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $201.90
Upside: +41.16%
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $23.53
Upside: +112.49%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $32.44
Upside: +32.55%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $122.59
Upside: +34.59%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.45
Upside: +106.90%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.28
Upside: +134.38%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.16
Upside: +1,143.78%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $9.28
Upside: +15,805.17%